Whereas the survival of patients with prostate, breast, and colorectal cancers was increased through the overexpression of Cx-43 [63,65,66], it was reduced in patients with bladder cancer, esophageal squamous cell carcinoma, and oral squamous cell carcinoma [67,68,69]. This evidence concerns the gene GJA1 and colorectal cancer.